Fig. 4From: Defibrotide improved the outcome of monocrotaline induced rat hepatic sinusoidal obstruction syndromeThe survival curve of each group. Group A: control group; Group B: HSOS model group; Group C: low dose LMWH group; Group D: high dose LMWH group; Group E: defibrotide group. The survival time between group E and B was significantly different (P = 0.028). The survival time between group B, C and D was similar (P>0.05).Back to article page